immune modulation therapies for the treatment of cardiovascular disease

History:

Merged with IntelliPharmaCeutics in 2009.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North America

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics:Clinical late (III)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: